Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Oct-22 7:13 PM View:  | Jain Rita EVP, Chief Medical Officer Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 35,863 | -- | -- | (100%) 35.86K to 0 | |
| 24-Oct-22 7:01 PM View: | Feczko Joseph M Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 148,127 | -- | -- | (100%) 148.13K to 0 | |
| 24-Oct-22 7:06 PM View: | Kanaya Susan M See Remarks Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 132,717 | -- | -- | (100%) 132.72K to 0 | |
| 24-Oct-22 6:58 PM View: | Cappel Markus J. Chief Bus. Officer & Treasurer | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 87,658 | -- | -- | (100%) 87.66K to 0 | |
| 24-Oct-22 6:57 PM View: | Butt Tausif EVP, Chief Operating Officer | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 10,870 | -- | -- | (100%) 10.87K to 0 | |
| 24-Oct-22 7:10 PM View: | Herron Jennifer Lyn Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 17,237 | -- | -- | (100%) 17.24K to 0 | |
| 24-Oct-22 7:08 PM View: | Parker Geoffrey M. Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 107,997 | -- | -- | (81%) 134.07K to 26.08K | |
| 24-Oct-22 7:01 PM View: | Schall Thomas J. President and CEO Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 2,393,350 | -- | -- | (100%) 2.39M to 0 | |
| 24-Oct-22 7:02 PM View: | Tyree James L Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 9,138 | -- | -- | (100%) 9.14K to 0 | |
| 24-Oct-22 7:10 PM View: | Edwards Thomas A. Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 143,306 | -- | -- | (100%) 143.31K to 0 | |
| 24-Oct-22 7:06 PM View: | Kanaya Susan M See Remarks Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 91,317 | -- | -- | (41%) 224.03K to 132.72K | |
| 24-Oct-22 7:08 PM View: | Parker Geoffrey M. Director | ChemoCentryx, Inc. (CCXI) | 20-Oct-22 | Disposition | 26,076 | -- | -- | (100%) 26.08K to 0 | |
| 18-Aug-22 4:48 PM View: | Kanaya Susan M EVP, CFO and Sec. Director | ChemoCentryx, Inc. (CCXI) | 16-Aug-22 | Option Exercise | 19,898 | $10.86 | $216,092.00 | 9% 224.03K to 243.93K | |
| 18-Aug-22 4:48 PM View: | Kanaya Susan M EVP, CFO and Sec. Director | ChemoCentryx, Inc. (CCXI) | 16-Aug-22 | Planned Option Sale | 19,898 | $50.95 | $1,013,790.00 | (8%) 243.93K to 224.03K | |
| 08-Aug-22 7:41 PM View: | Schall Thomas J. President and CEO Director | ChemoCentryx, Inc. (CCXI) | 04-Aug-22 | Planned Option Sale | 130,000 | $50.24 | $6,531,730.00 | (5%) 2.52M to 2.39M | |
| 08-Aug-22 7:21 PM View: | Cappel Markus J. Chief Bus. Officer & Treasurer | ChemoCentryx, Inc. (CCXI) | 04-Aug-22 | Private Sale (Planned) | 7,564 | $50.22 | $379,864.00 | (8%) 95.22K to 87.66K | |
| 08-Aug-22 7:33 PM View: | Kanaya Susan M EVP, CFO and Sec. Director | ChemoCentryx, Inc. (CCXI) | 04-Aug-22 | Planned Option Sale | 46,298 | $50.17 | $2,322,720.00 | (17%) 270.33K to 224.03K | |
| 08-Aug-22 7:41 PM View: | Schall Thomas J. President and CEO Director | ChemoCentryx, Inc. (CCXI) | 04-Aug-22 | Option Exercise | 130,000 | $14.28 | $1,856,400.00 | 5% 2.39M to 2.52M | |
| 08-Aug-22 7:27 PM View: | Tyree James L Director | ChemoCentryx, Inc. (CCXI) | 04-Aug-22 | Private Sale (Planned) | 10,000 | $50.22 | $502,200.00 | (52%) 19.14K to 9.14K | |
| 08-Aug-22 7:33 PM View: | Kanaya Susan M EVP, CFO and Sec. Director | ChemoCentryx, Inc. (CCXI) | 04-Aug-22 | Option Exercise | 46,298 | $6.50 | $300,805.00 | 21% 224.03K to 270.33K | |
| 30-Jun-22 8:27 PM View: | Herron Jennifer Lyn Director | ChemoCentryx, Inc. (CCXI) | 28-Jun-22 | Grant | 17,237 | -- | -- | 100% 0 to 17.24K | |
| 13-Jun-22 6:28 PM View: | Tyree James L Director | ChemoCentryx, Inc. (CCXI) | 09-Jun-22 | Sale (Planned) | 3,863 | $25.66 | $99,129.50 | (17%) 23.0K to 19.14K | |
| 31-May-22 9:24 PM View: | Edwards Thomas A. Director | ChemoCentryx, Inc. (CCXI) | 26-May-22 | Grant | 15,723 | -- | -- | 12% 127.58K to 143.31K | |
| 24-May-22 8:18 PM View: | Tyree James L Director | ChemoCentryx, Inc. (CCXI) | 20-May-22 | Option Exercise | 7,726 | -- | -- | 51% 15.28K to 23.0K | |
| 24-May-22 7:34 PM View: | McKinnell Henry A Director | ChemoCentryx, Inc. (CCXI) | 20-May-22 | Option Exercise | 7,726 | -- | -- | 12% 65.02K to 72.75K | |
| 24-May-22 8:13 PM View: | Parker Geoffrey M. Director | ChemoCentryx, Inc. (CCXI) | 20-May-22 | Option Exercise Duplicate | 7,726 | -- | -- | 5% 142.76K to 150.49K | |
| 24-May-22 7:27 PM View: | Jain Rita EVP, Chief Medical Officer Director | ChemoCentryx, Inc. (CCXI) | 20-May-22 | Option Exercise | 7,726 | -- | -- | 27% 28.14K to 35.86K | |
| 03-May-22 10:29 AM View: | Parker Geoffrey M. Director | ChemoCentryx, Inc. (CCXI) | 02-May-22 | Option Exercise | 12,500 | $14.42 | $180,250.00 | 10% 130.26K to 142.76K | |
| 29-Mar-22 7:50 PM View: | Jain Rita EVP, Chief Medical Officer Director | ChemoCentryx, Inc. (CCXI) | 27-Mar-22 | Option Exercise | 5,251 | -- | -- | 23% 22.89K to 28.14K | |
| 25-Jan-22 8:03 PM View: | Feczko Joseph M Director | ChemoCentryx, Inc. (CCXI) | 21-Jan-22 | Option Exercise | 37,500 | $15.41 | $577,750.00 | 34% 110.63K to 148.13K | |
| 04-Jan-22 10:00 PM View: | Kanaya Susan M EVP, CFO and Sec. Director | ChemoCentryx, Inc. (CCXI) | 01-Jan-22 | Payment of Exercise | 16,847 | $36.41 | $613,399.00 | (7%) 240.88K to 224.03K | |
| 04-Jan-22 10:00 PM View: | Schall Thomas J. President and CEO Director | ChemoCentryx, Inc. (CCXI) | 01-Jan-22 | Option Exercise | 84,234 | -- | -- | 4% 2.35M to 2.44M | |
| 04-Jan-22 10:00 PM View: | Cappel Markus J. Chief Bus. Officer & Treasurer | ChemoCentryx, Inc. (CCXI) | 01-Jan-22 | Payment of Exercise | 11,538 | $36.41 | $420,099.00 | (11%) 106.76K to 95.22K | |
| 04-Jan-22 10:00 PM View: | Kanaya Susan M EVP, CFO and Sec. Director | ChemoCentryx, Inc. (CCXI) | 01-Jan-22 | Option Exercise | 30,799 | -- | -- | 15% 210.08K to 240.88K | |
| 04-Jan-22 10:00 PM View: | Cappel Markus J. Chief Bus. Officer & Treasurer | ChemoCentryx, Inc. (CCXI) | 01-Jan-22 | Option Exercise | 20,934 | -- | -- | 24% 85.83K to 106.76K | |
| 04-Jan-22 10:00 PM View: | Schall Thomas J. President and CEO Director | ChemoCentryx, Inc. (CCXI) | 01-Jan-22 | Payment of Exercise | 45,698 | $36.41 | $1,663,860.00 | (2%) 2.44M to 2.39M | |
| 21-Dec-21 6:33 PM View: | Tyree James L Director | ChemoCentryx, Inc. (CCXI) | 17-Dec-21 | Option Exercise | 37,500 | $13.22 | $495,750.00 | 245% 15.28K to 52.77K | |
| 21-Dec-21 6:33 PM View: | Tyree James L Director | ChemoCentryx, Inc. (CCXI) | 17-Dec-21 | Market Option Sale (Planned) | 37,500 | $35.02 | $1,313,160.00 | (71%) 52.77K to 15.28K | |
| 03-Dec-21 7:39 PM View: | Schall Thomas J. President and CEO Director | ChemoCentryx, Inc. (CCXI) | 01-Dec-21 | Option Exercise | 45,936 | $10.88 | $499,994.00 | 2% 2.31M to 2.35M | |
| 13-Oct-21 7:05 PM View: | Vifor (international) Ltd 10% Owner | ChemoCentryx, Inc. (CCXI) | 12-Oct-21 | Market Sale | 4,000,000 | $39.43 | $157,720,000.00 | (44%) 9.19M to 5.19M | |
| 24-May-21 8:09 PM View: | Parker Geoffrey M. Director | ChemoCentryx, Inc. (CCXI) | 21-May-21 | Option Exercise Duplicate | 4,660 | -- | -- | 4% 125.6K to 130.26K | |
| 24-May-21 7:55 PM View: | Jain Rita Director | ChemoCentryx, Inc. (CCXI) | 21-May-21 | Option Exercise | 4,660 | -- | -- | 26% 18.23K to 22.89K | |
| 24-May-21 8:19 PM View: | Tyree James L Director | ChemoCentryx, Inc. (CCXI) | 21-May-21 | Option Exercise | 4,660 | -- | -- | 36% 13.07K to 17.73K | |
| 24-May-21 8:19 PM View: | Tyree James L Director | ChemoCentryx, Inc. (CCXI) | 21-May-21 | Market Option Sale (Planned) | 2,454 | $9.76 | $23,955.90 | (14%) 17.73K to 15.28K | |
| 24-May-21 7:39 PM View: | Edwards Thomas A. Director | ChemoCentryx, Inc. (CCXI) | 20-May-21 | Grant | 7,726 | -- | -- | 6% 119.86K to 127.58K | |
| 24-May-21 7:47 PM View: | Feczko Joseph M Director | ChemoCentryx, Inc. (CCXI) | 20-May-21 | Grant | 7,726 | -- | -- | 8% 102.9K to 110.63K | |
| 10-May-21 7:48 PM View: | Butt Tausif EVP, Chief Operating Officer | ChemoCentryx, Inc. (CCXI) | 07-May-21 | Market Purchase | 10,870 | $11.06 | $120,241.00 | 100% 0 to 10.87K | (5%) |
| 30-Mar-21 8:45 PM View: | Jain Rita Director | ChemoCentryx, Inc. (CCXI) | 27-Mar-21 | Option Exercise | 5,251 | -- | -- | 40% 12.97K to 18.23K | |
| 24-May-21 8:09 PM View: | Parker Geoffrey M. Director | ChemoCentryx, Inc. (CCXI) | 10-Mar-21 | Gift | 4,000 | -- | -- | (3%) 129.6K to 125.6K | |
| 08-Mar-21 8:28 PM View: | Parker Geoffrey M. Director | ChemoCentryx, Inc. (CCXI) | 05-Mar-21 | Market Sale | 30,000 | $56.38 | $1,691,470.00 | (19%) 159.6K to 129.6K | 81% |
